Pfizer Inc.
Antibodies Specific for CD47, PD-L1, and Uses Thereof

Abstract:

Antibodies that specifically bind to CD47 and antibodies that specifically bind to PD-L1 are provided, as well as CD47/PD-L1 bispecific antibodies. Also provided are uses of these antibodies, and related compositions and methods.